It was also reported that the enhancer of zeste homolog 2(EZH2) in breast cancer cells represses the transcription of miR-29b and miR-30d by catalyzing H3K27me3, thereby promoting the expression of LOXL4 [96]. The gene discussed is LOXL4; the disease is breast carcinoma.